FREQUENCY THERAPEUTICS, INC. (FREQ) News
Filter FREQ News Items
FREQ News Results
|Loading, please wait...|
Latest FREQ News From Around the Web
Below are the latest news stories about FREQUENCY THERAPEUTICS INC that investors may wish to consider to help them evaluate FREQ as an investment opportunity.
LEXINGTON, Mass., August 10, 2023--Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023.
It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will apply to trade on the NASDAQ under the ticker symbol KRRO.
Ainos (AIMD) stock is on the rise Friday with heavy trading despite a lack of news from the medical technologies company.
Frequency Therapeutics (FREQ) stock is rocketing higher on Friday with heavy trading following news that it will combine with Korro Bio.
Theseus Pharmaceuticals (THRX) stock is falling hard on Friday after the company announced poor results from a Phase 1/2 clinical trial.
Leslies (LESL) stock is falling on Friday after the company released its preliminary earnings report for the third quarter of 2023.
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Korro Bio Inc and Frequency Therapeutics Inc (NASDAQ: FREQ) announced an all-stock merger transaction. Under the merger agreement's terms, stockholders of Korro Bio will receive newly issued shares of Frequency Therapeutics. Frequency Therapeutics has discontinued developing its remyelination program for Multiple Sclerosis as it explores strategic alternatives for the program. Suppose Frequency Therapeutics has not otherwise monetized its remyelination program before the closing of the proposed